Serveur d'exploration sur l'Indium - Curation (Accueil)

Index « Auteurs » - entrée « M de Jong »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
M de Bruin < M de Jong < M de Lorgeril  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 30.
[0-20] [0 - 20][0 - 30][20-29][20-40]
Ident.Authors (with country if any)Title
000985 (2012) Improving radiopeptide pharmacokinetics by adjusting experimental conditions for bombesin receptor-targeted imaging of prostate cancer.
002887 (2007) Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumours.
003478 (2003) Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer.
003915 (2001) Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives.
003916 (2001) [177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients.
003B02 (2000) Use of the rat pancreatic CA20948 cell line for the comparison of radiolabelled peptides for receptor-targeted scintigraphy and radionuclide therapy.
003B26 (2001) Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumours.
003B70 (2000) Peptide receptor imaging and therapy.
003B86 (2000) Cholecystokinin receptor imaging using an octapeptide DTPA-CCK analogue in patients with medullary thyroid carcinoma.
003B95 (2000) Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy.
003D58 (2000) The role of radioactive somatostatin and its analogues in the control of tumor growth.
003D61 (1999) Preclinical and initial clinical evaluation of 111In-labeled nonsulfated CCK8 analog: a peptide for CCK-B receptor-targeted scintigraphy and radionuclide therapy.
003E34 (1999) Somatostatin receptor imaging and therapy of pancreatic endocrine tumors.
003E56 (1999) Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy.
003E58 (1999) Tumour uptake of the radiolabelled somatostatin analogue [DOTA0, TYR3]octreotide is dependent on the peptide amount.
003E99 (1999) Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapy.
004202 (1998) Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy.
004221 (1997) D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake.
004225 (1997) Effects of ligand priming and multiple-dose injection on tissue uptake of 111In-pentetreotide in rats.
004394 (1997) Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy.
004603 (1996) Inhibition of renal uptake of indium-111-DTPA-octreotide in vivo.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV2/Data/Main/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/Author.i -k "M de Jong" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/Author.i  \
                -Sk "M de Jong" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV2
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    Author.i
   |clé=    M de Jong
}}

Wicri

This area was generated with Dilib version V0.5.76.
Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024